跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Robimep - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Robimep
Approved
STANDARD
Robimep
Gufic Biosciences Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
362903a41322d6c5
Company
Gufic Biosciences Limited
Type
Standard
Approval Details
Approval Id
362903a41322d6c5
Drug Approval Philippines Name
Robimep
Product Name
Robimep
Registration Number
DRP-5882-05
Brand Name
Robimep
Generic Name
Omeprazole (as sodium)
Dosage Form
Lyophilized Powder for IV Injection/Infusion
Dosage Strength
40 mg
Manufacturer
Gufic Biosciences Limited
Importer
Suhitas Pharmaceuticals Inc
Distributor
Rx Global Sales and Mktg. Corp.
Company Detail Path
/organization/gufic-biosciences-limited
Issuance Date
28 September 2022
Expiry Date
09 December 2027
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
362903a41322d6c5
Type
Standard
Back to Philippines FDA Approvals